This is part of a series of reports discussing the activities, milestones, and outcomes of the Protection Options for Women Product Development Partnership (2011-2015) dedicated to expanding access to the Woman’s Condom. This report focuses on global activities and strategies designed to develop sustainable markets for the Woman’s Condom. In March 2016, the Woman’s Condom received WHO/UNFPA prequalification, an important step toward increasing global access.

PATH and the Bill & Melinda Gates Foundation co-hosted a consultation in November 2015 bringing together developers, manufacturers, and organizations interested in expanding access to pulse oximetry and oxygen concentrators in low-resources settings. This summary outlines key issues identified at the consultation including barriers to access, market size, and maintenance.

This is part of a series of reports discussing the activities, milestones, and outcomes of the Protection Options for Women Product Development Partnership (2011-2015) dedicated to expanding access to the Woman’s Condom. This report focuses on our work shaping and strengthening markets for the Woman’s Condom in China. In March 2016, the Woman’s Condom received WHO/UNFPA prequalification, an important step toward increasing global access.

This is part of a series of reports discussing the activities, milestones, and outcomes of the Protection Options for Women Product Development Partnership (2011-2015) dedicated to expanding access to the Woman’s Condom. This report focuses on our work shaping and strengthening markets for the Woman’s Condom in South Africa. In March 2016, the Woman’s Condom received WHO/UNFPA prequalification, an important step toward increasing global access.

As part of PATH’s work in vaccine and pharmaceutical delivery technologies, this report provides insight into country priorities for maternal immunization and characterizes the market for adult immunizations in select low- and middle-income countries. It outlines the landscape of vaccines with known and potential value in maternal immunization, summarizes global stakeholder and country-level program priorities for maternal immunization programs, provides demand estimates for high-priority maternal vaccines, and summarizes regulatory requirements.

Part of the Technology Updates series, this fact sheet describes PATH's work, in collaboration with Cascade Designs, to develop a portable, battery-powered, easy-to-use device that delivers consistent concentrations of chlorine to treat water in low-resource settings.

This is part of a series of reports discussing the activities, milestones, and outcomes of the Protection Options for Women Product Development Partnership (2011-2015) dedicated to expanding access to the Woman’s Condom. This report focuses on our innovative advocacy initiatives generated to create an enabling environment for female condom programming. In March 2016, the Woman’s Condom received WHO/UNFPA prequalification, an important step toward increasing global access.

The first issue in a multipart publication series that leverages PATH’s Installed Base and Forecasting Model to assess the global market for cold chain equipment innovations, this forecast focuses on passive freeze-safe vaccine carriers that can reduce vaccine product exposure to freezing temperatures during transportation and outreach in low-resource settings.

The goal of PATH’s Healthy Household Initiative (HHI) is to increase the accessibility, affordability, and use of health products by households in low-resource settings. In 2014, PATH worked with distribution partner Sakhi Unique Rural Enterprise (SURE) and financing partner Sakhi Samudaya Kosh (SSK) to pilot an HHI model in two districts of Maharashtra, India. The results of the pilot are outlined in this fact sheet.

The world is off track to achieve most of the targets defined in the globally agreed upon Global Vaccine Action Plan. The United States government—one of the largest contributors to global immunization efforts—has not yet articulated its strategy for meeting these globally agreed upon goals. This new policy report includes PATH’s recommendations for catalyzing US government leadership and maximizing impact in global immunization.

Critical gains in maternal, newborn, and child health across the globe during the past two decades provide inspiration for achieving the new vision set out through the recently ratified Sustainable Development Goals. These goals, combined with the launch of the Global Strategy for Women’s, Children’s, and Adolescents’ Health, embolden PATH to do even more to accelerate innovation to achieve the world we aspire to live in—a world where all women, newborns, children, and adolescents enjoy healthy and productive lives.

Neonatal infections are a major cause of newborn mortality in low-resource settings. In view of the World Health Organization’s new 2015 guidelines for outpatient treatment of neonatal sepsis when referral is not feasible, PATH reviewed a range of drug formulation, packaging, and delivery technologies that might be applied to gentamicin delivery for infants at primary care to improve safety, ease of delivery, and potentially expand access.

This document describes a quality assurance (QA) program for Ov16 rapid tests that can be implemented by onchocerciasis control and elimination programs to help ensure high-quality testing and to identify areas for improvement and change. Designed for policymakers and program planners wishing to implement Ov16 rapid testing, these guidelines describe some important basic principles and the main practical aspects of a QA program.

These key messages for policy- and decision-makers explain why next-generation immunization supply chains are needed to fulfill global health goals. They are intended to unite stakeholders in a common language around supply chain strengthening and may be used freely by partners when communicating about immunization supply chain issues and solutions.

The Woman’s Condom has been evaluated for acceptability, performance, and safety in clinical studies across five countries since 2004. This document provides summaries of the key studies implemented during development and validation of the Woman’s Condom as a new method for dual protection.

This fact sheet describes PATH’s work to improve immunization rates for women and young children in Ben Tre Province in Southern Vietnam through the introduction of a digital immunization registry. The new system, known as ImmReg, is saving time, reducing errors, and improving on-time immunization rates.

In Ba Ria-Vung Tau Province, Vietnam, PATH is testing a web- and mobile-based application that links local health care workers to the National Tuberculosis (TB) Treatment management database and sends short message service (SMS) text reminders to patients. This fact sheet describes how the new system is supporting TB treatment adherence and includes preliminary results.